Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Myeloid 2

Conditions

Polycythemia Vera 2Thrombosis 1Polycythemia 1Myeloproliferative Disorders 1

Interventions

Hydroxyurea 8ruxolitinib 5Aspirin 3peginterferon alfa-2b 2peginterferon alfa-2a 2liposomal amphotericin B 2Phlebotomy 2Early Intervention, Educational 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2pomalidomide 1givinostat hydrochloride 1givinostat 1bomedemstat 1anagrelide 1Pipobroman 1Pharmacogenomic Testing 1Ondansetron 1N(4)-oleylcytosine arabinoside 1Morphine 1Lenalidomide 1Ketamine 1Interferons 1Interferon-alpha 1Hypericum extract LI 160 1Fentanyl 1Dextromethorphan 1Caspofungin 1Asian ginseng 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Polycythemia Vera × Phlebotomy × Clear all
NCT06002490 2024-11-08

A Study to Evaluate P1101 in Japanese PV Patients

PharmaEssentia Japan K.K.

Phase 3 Completed
21 enrolled
Myeloid

Myeloproliferative Disorders, Polycythemia Vera

NCT01645124 2012-07-20

CYTO-PV

Consorzio Mario Negri Sud

Phase 3 Terminated
365 enrolled
Myeloid

Polycythemia, Polycythemia Vera, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡